{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:25:25Z","timestamp":1767626725600},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3,20]]},"DOI":"10.4103\/0366-6999.152683","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T08:47:38Z","timestamp":1425458858000},"page":"835-838","source":"Crossref","is-referenced-by-count":16,"title":["Effects of Immunosuppressants on Immune Response to Vaccine in Inflammatory Bowel Disease"],"prefix":"10.1097","volume":"128","author":[{"given":"Yuan","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Hua","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-23-20210129","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/ajg.2012.198","article-title":"5-aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: A meta-analysis of non-referral populations","volume":"107","author":"Nguyen","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R2-23-20210129","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/INF.0b013e31815cb239","article-title":"Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: Utility of PCR for early recognition and therapy","volume":"27","author":"Rau","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R3-23-20210129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","article-title":"The second European evidence-based consensus on the diagnosis and management of Crohn's disease: Current management","volume":"4","author":"Dignass","year":"2010","journal-title":"J Crohns Colitis"},{"key":"R4-23-20210129","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1056\/NEJMc1005805","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"363","author":"Ruffolo","year":"2010","journal-title":"N Engl J Med"},{"key":"R5-23-20210129","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10620-011-1980-8","article-title":"Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls","volume":"57","author":"Altun\u00f6z","year":"2012","journal-title":"Dig Dis Sci"},{"key":"R6-23-20210129","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1053\/j.gastro.2007.09.022","article-title":"Mortality by medication use among patients with inflammatory bowel disease, 1996-2003","volume":"133","author":"Hutfless","year":"2007","journal-title":"Gastroenterology"},{"key":"R7-23-20210129","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ajg.2009.523","article-title":"Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease","volume":"105","author":"Melmed","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R8-23-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.crohns.2009.02.010","article-title":"European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"3","author":"Rahier","year":"2009","journal-title":"J Crohns Colitis"},{"key":"R9-23-20210129","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/ajg.2009.733","article-title":"A practical guide to vaccinating the inflammatory bowel disease patient","volume":"105","author":"Wasan","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R10-23-20210129","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1002\/art.21386","article-title":"Infections in patients with rheumatoid arthritis treated with biologic agents","volume":"52","author":"Listing","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R11-23-20210129","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1136\/ard.2006.062760","article-title":"Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists","volume":"66","author":"Askling","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R14-23-20210129","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/S0264-410X(02)00112-3","article-title":"Pneumococcal polysaccharide vaccine: A systematic review of clinical effectiveness in adults","volume":"20","author":"Watson","year":"2002","journal-title":"Vaccine"},{"key":"R15-23-20210129","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ibd.21800","article-title":"Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: A prospective study","volume":"18","author":"Fiorino","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"R16-23-20210129","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/annrheumdis-2012-202658","article-title":"Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy","volume":"72","author":"Mori","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R17-23-20210129","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.crohns.2013.09.022","article-title":"Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine","volume":"8","author":"Lee","year":"2014","journal-title":"J Crohns Colitis"},{"key":"R18-23-20210129","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/0886022X.2010.486498","article-title":"Immune response after a single vaccination against 2009 influenza A H1N1 in hemodialysis patients","volume":"32","author":"Temiz","year":"2010","journal-title":"Ren Fail"},{"key":"R19-23-20210129","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1750-2659.2009.00088.x","article-title":"H1N1 swine origin influenza infection in the United States and Europe in 2009 may be similar to H1N1 seasonal influenza infection in two Australian states in 2007 and 2008","volume":"3","author":"Kelly","year":"2009","journal-title":"Influenza Other Respir Viruses"},{"key":"R20-23-20210129","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2008.120","article-title":"Immune response to influenza vaccine in children with inflammatory bowel disease","volume":"104","author":"Lu","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R21-23-20210129","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1473-3099(09)70175-6","article-title":"Influenza in immunosuppressed populations: A review of infection frequency, morbidity, mortality, and vaccine responses","volume":"9","author":"Kunisaki","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"R22-23-20210129","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00054725-200409000-00028","article-title":"Guidelines for immunizations in patients with inflammatory bowel disease","volume":"10","author":"Sands","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"R23-23-20210129","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.crohns.2012.05.011","article-title":"Immune response to influenza A\/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-a agents: Effects of combined therapy with immunosuppressants","volume":"7","author":"Andrisani","year":"2013","journal-title":"J Crohns Colitis"},{"key":"R24-23-20210129","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/gutjnl-2011-300256","article-title":"Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease","volume":"61","author":"Cullen","year":"2012","journal-title":"Gut"},{"key":"R25-23-20210129","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ibd.21284","article-title":"Viral hepatitis and inflammatory bowel disease","volume":"16","author":"Hou","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"R26-23-20210129","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ibd.21147","article-title":"Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France","volume":"16","author":"Chevaux","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"R27-23-20210129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ajg.2008.4","article-title":"Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: A nationwide, multicenter study","volume":"104","author":"Loras","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R28-23-20210129","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.vaccine.2013.04.059","article-title":"Factors predicting response to hepatitis B vaccination in patients with inflammatory bowel disease","volume":"31","author":"Sempere","year":"2013","journal-title":"Vaccine"},{"key":"R29-23-20210129","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/MIB.0b013e31827febe9","article-title":"Kinetics of anti-hepatitis B surface antigen titers after hepatitis B vaccination in patients with inflammatory bowel disease","volume":"19","author":"Gisbert","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"R30-23-20210129","first-page":"548","article-title":"Early versus late immune mediated inflammatory diseases","volume":"74","author":"Fiocchi","year":"2011","journal-title":"Acta Gastroenterol Belg"},{"key":"R31-23-20210129","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of adults","volume":"55","author":"Mast","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R32-23-20210129","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1572-0241.2007.01609.x","article-title":"Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases","volume":"103","author":"W\u00f6rns","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R33-23-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1440-1746.2004.03398.x","article-title":"Hepatitis B vaccine boosters: Is there a clinical need in high endemicity populations?","volume":"20","author":"John","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"R34-23-20210129","first-page":"331","article-title":"Adequate rate of response to hepatitis B virus vaccination in patients with inflammatory bowel disease","volume":"132","author":"Vida","year":"2009","journal-title":"Med Clin (Barc"},{"key":"R35-23-20210129","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.MIB.0000437736.91712.a1","article-title":"Efficacy of hepatitis A vaccination and factors impacting on seroconversion in patients with inflammatory bowel disease","volume":"20","author":"Park","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"R36-23-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2036.2012.05150.x","article-title":"Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: Implications for serological testing and vaccination guidelines","volume":"36","author":"Kopylov","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R37-23-20210129","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cgh.2007.02.035","article-title":"Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease","volume":"5","author":"Mamula","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R38-23-20210129","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2174\/138945010790310009","article-title":"How to manage the infectious risk under anti-TNF in inflammatory bowel disease","volume":"11","author":"Culver","year":"2010","journal-title":"Curr Drug Targets"},{"key":"R40-23-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1586\/17474124.2014.934672","article-title":"Vaccinating the inflammatory bowel disease patient","volume":"9","author":"Desalermos","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.152683","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:33:44Z","timestamp":1623958424000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201503200-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,20]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.152683","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3,20]]}}}